Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

688 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer: A Sub-Analysis from the ENABLE Study for PCa.
Mita K, Izumi K, Goriki A, Tasaka R, Hatayama T, Shima T, Kato Y, Kamiyama M, Inoue S, Tanaka N, Hoshi S, Okamura T, Yoshio Y, Enokida H, Chikazawa I, Kawai N, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Kadono Y, Mizokami A. Mita K, et al. Among authors: takahara s. Cancers (Basel). 2024 Jan 24;16(3):508. doi: 10.3390/cancers16030508. Cancers (Basel). 2024. PMID: 38339260 Free PMC article.
Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study.
Kadono Y, Konaka H, Nohara T, Izumi K, Anai S, Fujimoto K, Koguchi T, Ishibashi K, Kawai N, Nakane K, Iba A, Masumori N, Takahara S, Mizokami A. Kadono Y, et al. Among authors: takahara s. Cancers (Basel). 2023 May 13;15(10):2745. doi: 10.3390/cancers15102745. Cancers (Basel). 2023. PMID: 37345082 Free PMC article.
Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCa.
Tanaka N, Izumi K, Nakai Y, Shima T, Kato Y, Mita K, Kamiyama M, Inoue S, Hoshi S, Okamura T, Yoshio Y, Enokida H, Chikazawa I, Kawai N, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Mizokami A. Tanaka N, et al. Among authors: takahara s. Prostate. 2025 Jan;85(1):21-29. doi: 10.1002/pros.24796. Epub 2024 Sep 20. Prostate. 2025. PMID: 39301921 Clinical Trial.
Determination of urine volume and glomerular filtration rate using d-serine and d-asparagine.
Tanaka R, Sakai S, Taniguchi A, Kawamura M, Higa-Maegawa Y, Matsumura S, Fukae S, Nakazawa S, Kimura-Ohba S, Horio M, Takahara S, Imamura R, Nonomura N, Mizui M, Isaka Y, Kakuta Y, Kimura T. Tanaka R, et al. Among authors: takahara s. Nephrol Dial Transplant. 2024 Nov 21:gfae279. doi: 10.1093/ndt/gfae279. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 39572072
Kinetic analysis of D-Alanine upon oral intake in humans.
Kimura T, Sakai S, Horio M, Takahara S, Ishigo S, Nakane M, Negishi E, Imoto H, Mita M, Hamase K, Higa-Maekawa Y, Kakuta Y, Mizui M, Isaka Y. Kimura T, et al. Among authors: takahara s. Amino Acids. 2024 Oct 14;56(1):61. doi: 10.1007/s00726-024-03421-6. Amino Acids. 2024. PMID: 39400632 Free PMC article.
Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma.
Yamamoto A, Kawashima A, Sakai S, Mita M, Sassi N, Inoguchi S, Horibe Y, Yoshimura A, Tani M, Yutong L, Okuda Y, Oka T, Uemura T, Yamamichi G, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Hatano K, Kakuta Y, Imamura R, Takahara S, Kimura T, Nonomura N. Yamamoto A, et al. Among authors: takahara s. Biochem Biophys Res Commun. 2024 Nov 12;733:150701. doi: 10.1016/j.bbrc.2024.150701. Epub 2024 Sep 14. Biochem Biophys Res Commun. 2024. PMID: 39326256 Free article.
688 results